Blood Clot Warning Clouds Future of J&J's Ortho Evra Contraceptive Patch

Drug Industry Daily
KEYWORDS FDA / labeling
A A

Lawyers and consumer groups are breathing down Johnson & Johnson’s (J&J) neck following a warning issued by the company and the FDA last week that its contraceptive patch Ortho Evra may put patients at risk for blood clots and other serious side-effects.

To View This Article:

Login

Subscribe To Drug Industry Daily